Abstract
BackgroundSeveral infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children.MethodsStool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T- test.ResultsPre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline.ConclusionsThere are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment.
Highlights
The importance of the gut microbiome in host health is becoming increasingly clear as studies characterise the nutritional, biochemical and immunological function of the microbes
There are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment
There is a paucity of studies describing/investigating the role of the gut microbiome in infection, pathology and acquired immunity in children exposed to helminth infections
Summary
The importance of the gut microbiome in host health is becoming increasingly clear as studies characterise the nutritional, biochemical and immunological function of the microbes. Several studies have highlighted that significant alteration of the gut microbiome (dysbiosis) can influence susceptibility to non-infectious diseases [1], while experimental studies have described both beneficial and detrimental effects of gut microbes on host health and response to pathogens and therapeutics [2,3]. The most important helminth parasite in sub-Saharan Africa is Schistosoma haematobium which causes urogenital schistosomiasis, commonly known as bilharzia. Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs uninfected children
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have